Drug manufacturer Moderna says it will begin testing a variant-specific version of its COVID-19 vaccine that would target the B1351 variant first detected in South Africa.
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy. I Agree
Notice of Redirection & Site Closure
As of March 29, 2024, Readers can get the latest news at https://w.news. All posts and content on WNewsNetwork.com are archived and will be transferred to W.News over the next few months.
WNewsNetwork.com will officially shut down on June 30, 2024.